Trial NCT00880009

View at ClinicalTrials.gov 
Org. Study IDs: 3160A6-2207
Secondary IDs: 2008-006252-21 B1871010

Last trial update was posted on 2021-09-27

MeSH Interventions

Bosutinib Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Results are not provided because the study was terminated prior to part 2 due to unfavorable risk benefit ratio of the study treatment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID